Viking Therapeutics Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update
Go back to Viking Therapeutics Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update| ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) | Delayed: 65.67 +0.60 (0.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $65.07 | 52 Week High | $5.17 | |||
| Open | $63.00 | 52 Week Low | $0.94 | |||
| Day High | $69.17 | P/E | N/A | |||
| Day Low | $62.56 | EPS | $0.00 | |||
| Volume | 1,612,355 | |||||
